NEWS
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes
IceCure Medical announced that the FDA has granted regulatory clearance for its next-generation XSense™ Cryoablation System with CryoProbes. The system, which uses extreme cold to destroy tissues, is cleared for the same indications as its predecessor, ProSense®. These include applications in general surgery, dermatology, neurology, thoracic surgery, ENT, gynecology, oncology, proctology, and urology. The technology addresses conditions such as fibroadenomas, kidney tissue, liver metastases, tumors, skin lesions, and warts. CEO Eyal Shamir stated that this clearance validates the safety and efficacy of the platform, potentially enabling the system to address unmet medical needs in the U.S.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
950Followers
63Following
6415Visitors
Follow
Trytosaveabit : It will more than likely be shorted on any pump! Hehehe
Jaguar8OP Trytosaveabit: And we both know it
Trytosaveabit Jaguar8OP: Yup yup! If I don’t I will be beyond surprised! Happy but surprised
Jaguar8OP Trytosaveabit: I hate shorts I hate shorts I hate shorts
Trytosaveabit Jaguar8OP: You and me both brother
74137893 : me 3